Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be ...
The NEJM publication of the ASCENT-04 results follow a data presentation at the 2025 ASCO Annual Congress, as well a simultaneous presentation at the 2025 European Society for Medical Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results